Company name
2022Founder
Mark Daly is a human geneticist whose research develops statistical methods to discover and interpret genetic variation underlying complex human disease. As a scientific founder of Maze Therapeutics, he brings expertise in human genetics and genomic variation to the company; his work has also included research on the use of genomic information in clinical settings.
Scientific Founder
Ph.D. in human genetics
Cosign details are not available yet.
More profile details are not available yet.